Nicergoline tablets are a calcium‑channel blocker that selectively dilates cerebral vessels, improving brain blood flow, oxygen, and glucose supply. They are indicated for treatment of cerebral vasospasm, cerebral ischemia, and cerebral infarction.
The recommended oral dose is 1–2 tablets (5–10 mg) three times daily, or as prescribed by a physician. Common adverse reactions are mild and include dizziness, fatigue, and nausea, which usually resolve on their own. The tablets are pale‑yellow and supplied in tablet form. This manual is written in Chinese.